BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Khattri S, Shemer A, Rozenblit M, Dhingra N, Czarnowicki T, Finney R, Gilleaudeau P, Sullivan-Whalen M, Zheng X, Xu H, Cardinale I, de Guzman Strong C, Gonzalez J, Suárez-Fariñas M, Krueger JG, Guttman-Yassky E. Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology. J Allergy Clin Immunol 2014;133:1626-34. [PMID: 24786238 DOI: 10.1016/j.jaci.2014.03.003] [Cited by in Crossref: 105] [Cited by in F6Publishing: 96] [Article Influence: 13.1] [Reference Citation Analysis]
Number Citing Articles
1 Renert-yuval Y, Guttman-yassky E. Monoclonal antibodies for the treatment of atopic dermatitis. Current Opinion in Allergy & Clinical Immunology 2018;18:356-64. [DOI: 10.1097/aci.0000000000000455] [Cited by in Crossref: 7] [Article Influence: 1.8] [Reference Citation Analysis]
2 Song T, Pavel AB, Wen H, Malik K, Estrada Y, Gonzalez J, Hashim PW, Nia JK, Baum D, Kimmel G, Singer GK, Krueger JG, Guttman-yassky E. An integrated model of alopecia areata biomarkers highlights both TH1 and TH2 upregulation. Journal of Allergy and Clinical Immunology 2018;142:1631-1634.e13. [DOI: 10.1016/j.jaci.2018.06.029] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
3 Wu J, Guttman-yassky E. Efficacy of biologics in atopic dermatitis. Expert Opinion on Biological Therapy 2020;20:525-38. [DOI: 10.1080/14712598.2020.1722998] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 8.5] [Reference Citation Analysis]
4 Martel BC, Blom L, Dyring-andersen B, Skov L, Thestrup-pedersen K, Skov S, Skak K, Poulsen LK. Human Atopic Dermatitis Skin-derived T Cells can Induce a Reaction in Mouse Keratinocytes in vivo. Scand J Immunol 2015;82:125-34. [DOI: 10.1111/sji.12316] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
5 Qin R, Lampel HP. Review of Occupational Contact Dermatitis—Top Allergens, Best Avoidance Measures. Curr Treat Options Allergy 2015;2:349-64. [DOI: 10.1007/s40521-015-0063-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
6 Dubin C, Del Duca E, Guttman-Yassky E. Drugs for the Treatment of Chronic Hand Eczema: Successes and Key Challenges. Ther Clin Risk Manag 2020;16:1319-32. [PMID: 33408476 DOI: 10.2147/TCRM.S292504] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Janikowska G, Kurzeja E, Janikowski M, Strzałka-Mrozik B, Pyka-Pająk A, Janikowski T. The Effect of Cyclosporine A on Dermal Fibroblast Cell - Transcriptomic Analysis of Inflammatory Response Pathway. Curr Pharm Biotechnol 2020;21:1213-23. [PMID: 32297577 DOI: 10.2174/1389201021666200416103928] [Reference Citation Analysis]
8 Hamilton JD, Ungar B, Guttman-Yassky E. Drug evaluation review: dupilumab in atopic dermatitis. Immunotherapy 2015;7:1043-58. [PMID: 26598956 DOI: 10.2217/imt.15.69] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 10.7] [Reference Citation Analysis]
9 Suárez-fariñas M, Ungar B, Correa da Rosa J, Ewald DA, Rozenblit M, Gonzalez J, Xu H, Zheng X, Peng X, Estrada YD, Dillon SR, Krueger JG, Guttman-yassky E. RNA sequencing atopic dermatitis transcriptome profiling provides insights into novel disease mechanisms with potential therapeutic implications. Journal of Allergy and Clinical Immunology 2015;135:1218-27. [DOI: 10.1016/j.jaci.2015.03.003] [Cited by in Crossref: 144] [Cited by in F6Publishing: 141] [Article Influence: 20.6] [Reference Citation Analysis]
10 Brunner PM, Khattri S, Garcet S, Finney R, Oliva M, Dutt R, Fuentes-duculan J, Zheng X, Li X, Bonifacio KM, Kunjravia N, Coats I, Cueto I, Gilleaudeau P, Sullivan-whalen M, Suárez-fariñas M, Krueger JG, Guttman-yassky E. A mild topical steroid leads to progressive anti-inflammatory effects in the skin of patients with moderate-to-severe atopic dermatitis. Journal of Allergy and Clinical Immunology 2016;138:169-78. [DOI: 10.1016/j.jaci.2015.12.1323] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 7.7] [Reference Citation Analysis]
11 Wollenberg A, Howell MD, Guttman-Yassky E, Silverberg JI, Kell C, Ranade K, Moate R, van der Merwe R. Treatment of atopic dermatitis with tralokinumab, an anti-IL-13 mAb. J Allergy Clin Immunol 2019;143:135-41. [PMID: 29906525 DOI: 10.1016/j.jaci.2018.05.029] [Cited by in Crossref: 159] [Cited by in F6Publishing: 133] [Article Influence: 39.8] [Reference Citation Analysis]
12 Esaki H, Brunner PM, Renert-yuval Y, Czarnowicki T, Huynh T, Tran G, Lyon S, Rodriguez G, Immaneni S, Johnson DB, Bauer B, Fuentes-duculan J, Zheng X, Peng X, Estrada YD, Xu H, de Guzman Strong C, Suárez-fariñas M, Krueger JG, Paller AS, Guttman-yassky E. Early-onset pediatric atopic dermatitis is T H 2 but also T H 17 polarized in skin. Journal of Allergy and Clinical Immunology 2016;138:1639-51. [DOI: 10.1016/j.jaci.2016.07.013] [Cited by in Crossref: 165] [Cited by in F6Publishing: 161] [Article Influence: 27.5] [Reference Citation Analysis]
13 Simpson EL, Flohr C, Eichenfield LF, Bieber T, Sofen H, Taïeb A, Owen R, Putnam W, Castro M, DeBusk K, Lin CY, Voulgari A, Yen K, Omachi TA. Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE). J Am Acad Dermatol 2018;78:863-871.e11. [PMID: 29353026 DOI: 10.1016/j.jaad.2018.01.017] [Cited by in Crossref: 153] [Cited by in F6Publishing: 129] [Article Influence: 38.3] [Reference Citation Analysis]
14 Guttman-Yassky E, Bissonnette R, Ungar B, Suárez-Fariñas M, Ardeleanu M, Esaki H, Suprun M, Estrada Y, Xu H, Peng X, Silverberg JI, Menter A, Krueger JG, Zhang R, Chaudhry U, Swanson B, Graham NMH, Pirozzi G, Yancopoulos GD, D Hamilton JD. Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis. J Allergy Clin Immunol 2019;143:155-72. [PMID: 30194992 DOI: 10.1016/j.jaci.2018.08.022] [Cited by in Crossref: 176] [Cited by in F6Publishing: 151] [Article Influence: 44.0] [Reference Citation Analysis]
15 Ewald DA, Malajian D, Krueger JG, Workman CT, Wang T, Tian S, Litman T, Guttman-Yassky E, Suárez-Fariñas M. Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathways. BMC Med Genomics 2015;8:60. [PMID: 26459294 DOI: 10.1186/s12920-015-0133-x] [Cited by in Crossref: 75] [Cited by in F6Publishing: 74] [Article Influence: 10.7] [Reference Citation Analysis]
16 Heeringa JJ, Fieten KB, Bruins FM, van Hoffen E, Knol EF, Pasmans SGMA, van Zelm MC. Treatment for moderate to severe atopic dermatitis in alpine and moderate maritime climates differentially affects helper T cells and memory B cells in children. Clin Exp Allergy 2018;48:679-90. [PMID: 29575251 DOI: 10.1111/cea.13136] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
17 Ungar B, Garcet S, Gonzalez J, Dhingra N, Correa da Rosa J, Shemer A, Krueger JG, Suarez-farinas M, Guttman-yassky E. An Integrated Model of Atopic Dermatitis Biomarkers Highlights the Systemic Nature of the Disease. Journal of Investigative Dermatology 2017;137:603-13. [DOI: 10.1016/j.jid.2016.09.037] [Cited by in Crossref: 85] [Cited by in F6Publishing: 77] [Article Influence: 17.0] [Reference Citation Analysis]
18 Glickman JW, Dubin C, Renert-Yuval Y, Dahabreh D, Kimmel GW, Auyeung K, Estrada YD, Singer G, Krueger JG, Pavel AB, Guttman-Yassky E. Cross-sectional study of blood biomarkers of patients with moderate to severe alopecia areata reveals systemic immune and cardiovascular biomarker dysregulation. J Am Acad Dermatol 2021;84:370-80. [PMID: 32376430 DOI: 10.1016/j.jaad.2020.04.138] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
19 Guttman-Yassky E, Krueger JG. Atopic dermatitis and psoriasis: two different immune diseases or one spectrum? Curr Opin Immunol 2017;48:68-73. [PMID: 28869867 DOI: 10.1016/j.coi.2017.08.008] [Cited by in Crossref: 138] [Cited by in F6Publishing: 127] [Article Influence: 27.6] [Reference Citation Analysis]
20 Brunner PM, Israel A, Zhang N, Leonard A, Wen HC, Huynh T, Tran G, Lyon S, Rodriguez G, Immaneni S, Wagner A, Zheng X, Estrada YD, Xu H, Krueger JG, Paller AS, Guttman-Yassky E. Early-onset pediatric atopic dermatitis is characterized by TH2/TH17/TH22-centered inflammation and lipid alterations. J Allergy Clin Immunol 2018;141:2094-106. [PMID: 29731129 DOI: 10.1016/j.jaci.2018.02.040] [Cited by in Crossref: 84] [Cited by in F6Publishing: 82] [Article Influence: 21.0] [Reference Citation Analysis]
21 Guttman‐yassky E, Hanifin JM, Boguniewicz M, Wollenberg A, Bissonnette R, Purohit V, Kilty I, Tallman AM, Zielinski MA. The role of phosphodiesterase 4 in the pathophysiology of atopic dermatitis and the perspective for its inhibition. Exp Dermatol 2018. [DOI: 10.1111/exd.13808] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
22 Miyano K, Tsunemi Y. Current treatments for atopic dermatitis in Japan. J Dermatol 2021;48:140-51. [PMID: 33377547 DOI: 10.1111/1346-8138.15730] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Datsi A, Steinhoff M, Ahmad F, Alam M, Buddenkotte J. Interleukin-31: The "itchy" cytokine in inflammation and therapy. Allergy 2021. [PMID: 33629401 DOI: 10.1111/all.14791] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
24 Korolczuk A, Caban K, Amarowicz M, Czechowska G, Irla-Miduch J. Oxidative Stress and Liver Morphology in Experimental Cyclosporine A-Induced Hepatotoxicity. Biomed Res Int 2016;2016:5823271. [PMID: 27298826 DOI: 10.1155/2016/5823271] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
25 Bilimoria SN, Lio PA. Biologics for Allergic Dermatologic Diseases. Curr Allergy Asthma Rep 2020;20:35. [PMID: 32506208 DOI: 10.1007/s11882-020-00923-7] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Brunner PM, Suárez-Fariñas M, He H, Malik K, Wen HC, Gonzalez J, Chan TC, Estrada Y, Zheng X, Khattri S, Dattola A, Krueger JG, Guttman-Yassky E. The atopic dermatitis blood signature is characterized by increases in inflammatory and cardiovascular risk proteins. Sci Rep 2017;7:8707. [PMID: 28821884 DOI: 10.1038/s41598-017-09207-z] [Cited by in Crossref: 76] [Cited by in F6Publishing: 77] [Article Influence: 15.2] [Reference Citation Analysis]
27 Chen BR, Hsu KT, Hsu WH, Lee BH, Li TL, Chan YL, Wu CJ. Immunomodulation and mechanisms of fucoidan from Cladosiphon okamuranus ameliorates atopic dermatitis symptoms. Int J Biol Macromol 2021;189:537-43. [PMID: 34416266 DOI: 10.1016/j.ijbiomac.2021.08.001] [Reference Citation Analysis]
28 Möbus L, Rodriguez E, Harder I, Stölzl D, Boraczynski N, Gerdes S, Kleinheinz A, Abraham S, Heratizadeh A, Handrick C, Haufe E, Werfel T, Schmitt J, Weidinger S; TREATgermany study group. Atopic dermatitis displays stable and dynamic skin transcriptome signatures. J Allergy Clin Immunol 2021;147:213-23. [PMID: 32615169 DOI: 10.1016/j.jaci.2020.06.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
29 Song H, Kim WS, Mushtaq S, Park JM, Choi S, Cho J, Lim S, Byun E. A novel chrysin derivative produced by gamma irradiation attenuates 2,4-dinitrochlorobenzene-induced atopic dermatitis-like skin lesions in Balb/c mice. Food and Chemical Toxicology 2019;128:223-32. [DOI: 10.1016/j.fct.2019.03.048] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
30 Werfel T, Allam JP, Biedermann T, Eyerich K, Gilles S, Guttman-Yassky E, Hoetzenecker W, Knol E, Simon HU, Wollenberg A, Bieber T, Lauener R, Schmid-Grendelmeier P, Traidl-Hoffmann C, Akdis CA. Cellular and molecular immunologic mechanisms in patients with atopic dermatitis. J Allergy Clin Immunol 2016;138:336-49. [PMID: 27497276 DOI: 10.1016/j.jaci.2016.06.010] [Cited by in Crossref: 276] [Cited by in F6Publishing: 263] [Article Influence: 55.2] [Reference Citation Analysis]
31 Hamilton JD, Suárez-fariñas M, Dhingra N, Cardinale I, Li X, Kostic A, Ming JE, Radin AR, Krueger JG, Graham N, Yancopoulos GD, Pirozzi G, Guttman-yassky E. Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis. Journal of Allergy and Clinical Immunology 2014;134:1293-300. [DOI: 10.1016/j.jaci.2014.10.013] [Cited by in Crossref: 252] [Cited by in F6Publishing: 236] [Article Influence: 31.5] [Reference Citation Analysis]
32 Luger T, Amagai M, Dreno B, Dagnelie MA, Liao W, Kabashima K, Schikowski T, Proksch E, Elias PM, Simon M, Simpson E, Grinich E, Schmuth M. Atopic dermatitis: Role of the skin barrier, environment, microbiome, and therapeutic agents. J Dermatol Sci 2021;102:142-57. [PMID: 34116898 DOI: 10.1016/j.jdermsci.2021.04.007] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Czarnowicki T, Krueger JG, Guttman-Yassky E. Novel concepts of prevention and treatment of atopic dermatitis through barrier and immune manipulations with implications for the atopic march. J Allergy Clin Immunol 2017;139:1723-34. [PMID: 28583445 DOI: 10.1016/j.jaci.2017.04.004] [Cited by in Crossref: 131] [Cited by in F6Publishing: 108] [Article Influence: 26.2] [Reference Citation Analysis]
34 Malajian D, Guttman-yassky E. New pathogenic and therapeutic paradigms in atopic dermatitis. Cytokine 2015;73:311-8. [DOI: 10.1016/j.cyto.2014.11.023] [Cited by in Crossref: 66] [Cited by in F6Publishing: 60] [Article Influence: 9.4] [Reference Citation Analysis]
35 Brunner PM, Guttman-Yassky E, Leung DY. The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies. J Allergy Clin Immunol 2017;139:S65-76. [PMID: 28390479 DOI: 10.1016/j.jaci.2017.01.011] [Cited by in Crossref: 226] [Cited by in F6Publishing: 212] [Article Influence: 45.2] [Reference Citation Analysis]
36 Zhong Y, Qin K, Li L, Liu H, Xie Z, Zeng K. Identification of Immunological Biomarkers of Atopic Dermatitis by Integrated Analysis to Determine Molecular Targets for Diagnosis and Therapy. Int J Gen Med 2021;14:8193-209. [PMID: 34815693 DOI: 10.2147/IJGM.S331119] [Reference Citation Analysis]
37 Totté JE, van der Feltz WT, Hennekam M, van Belkum A, van Zuuren EJ, Pasmans SG. Prevalence and odds of Staphylococcus aureus carriage in atopic dermatitis: a systematic review and meta-analysis. Br J Dermatol 2016;175:687-95. [PMID: 26994362 DOI: 10.1111/bjd.14566] [Cited by in Crossref: 148] [Cited by in F6Publishing: 135] [Article Influence: 24.7] [Reference Citation Analysis]
38 Glocova I, Brück J, Geisel J, Müller-hermelink E, Widmaier K, Yazdi AS, Röcken M, Ghoreschi K. Induction of skin-pathogenic Th22 cells by epicutaneous allergen exposure. Journal of Dermatological Science 2017;87:268-77. [DOI: 10.1016/j.jdermsci.2017.06.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
39 Noda S, Suárez-fariñas M, Ungar B, Kim SJ, de Guzman Strong C, Xu H, Peng X, Estrada YD, Nakajima S, Honda T, Shin JU, Lee H, Krueger JG, Lee K, Kabashima K, Guttman-yassky E. The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization. Journal of Allergy and Clinical Immunology 2015;136:1254-64. [DOI: 10.1016/j.jaci.2015.08.015] [Cited by in Crossref: 275] [Cited by in F6Publishing: 247] [Article Influence: 39.3] [Reference Citation Analysis]
40 Brunner PM, Leung DYM, Guttman-Yassky E. Immunologic, microbial, and epithelial interactions in atopic dermatitis. Ann Allergy Asthma Immunol 2018;120:34-41. [PMID: 29126710 DOI: 10.1016/j.anai.2017.09.055] [Cited by in Crossref: 76] [Cited by in F6Publishing: 68] [Article Influence: 15.2] [Reference Citation Analysis]
41 Malik K, He H, Huynh TN, Tran G, Mueller K, Doytcheva K, Renert-Yuval Y, Czarnowicki T, Magidi S, Chou M, Estrada YD, Wen HC, Peng X, Xu H, Zheng X, Krueger JG, Paller AS, Guttman-Yassky E. Ichthyosis molecular fingerprinting shows profound TH17 skewing and a unique barrier genomic signature. J Allergy Clin Immunol 2019;143:604-18. [PMID: 29803800 DOI: 10.1016/j.jaci.2018.03.021] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 6.8] [Reference Citation Analysis]
42 Dimitriades VR, Wisner E. Treating pediatric atopic dermatitis: current perspectives. Pediatric Health Med Ther 2015;6:93-9. [PMID: 29388578 DOI: 10.2147/PHMT.S72461] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
43 Brunner PM, Emerson RO, Tipton C, Garcet S, Khattri S, Coats I, Krueger JG, Guttman-yassky E. Nonlesional atopic dermatitis skin shares similar T-cell clones with lesional tissues. Allergy 2017;72:2017-25. [DOI: 10.1111/all.13223] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 6.8] [Reference Citation Analysis]
44 Elias MS, Long HA, Newman CF, Wilson PA, West A, McGill PJ, Wu KC, Donaldson MJ, Reynolds NJ. Proteomic analysis of filaggrin deficiency identifies molecular signatures characteristic of atopic eczema. J Allergy Clin Immunol 2017;140:1299-309. [PMID: 28479159 DOI: 10.1016/j.jaci.2017.01.039] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 4.4] [Reference Citation Analysis]
45 Serra-baldrich E, de Frutos J, Jáuregui I, Armario-hita J, Silvestre J, Herraez L, Martín-santiago A, Valero A, Sastre J. Changing perspectives in atopic dermatitis. Allergologia et Immunopathologia 2018;46:397-412. [DOI: 10.1016/j.aller.2017.07.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
46 Sicherer SH, Leung DY. Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects in 2014. J Allergy Clin Immunol 2015;135:357-67. [PMID: 25662305 DOI: 10.1016/j.jaci.2014.12.1906] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
47 Noda S, Krueger JG, Guttman-Yassky E. The translational revolution and use of biologics in patients with inflammatory skin diseases. J Allergy Clin Immunol 2015;135:324-36. [PMID: 25541257 DOI: 10.1016/j.jaci.2014.11.015] [Cited by in Crossref: 126] [Cited by in F6Publishing: 106] [Article Influence: 15.8] [Reference Citation Analysis]
48 Kim YW, Ko EA, Jung SC, Lee D, Seo Y, Kim S, Kim JH, Bang H, Zhou T, Ko JH. Transcriptomic insight into the translational value of two murine models in human atopic dermatitis. Sci Rep 2021;11:6616. [PMID: 33758305 DOI: 10.1038/s41598-021-86049-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Esaki H, Ewald DA, Ungar B, Rozenblit M, Zheng X, Xu H, Estrada YD, Peng X, Mitsui H, Litman T, Suárez-Fariñas M, Krueger JG, Guttman-Yassky E. Identification of novel immune and barrier genes in atopic dermatitis by means of laser capture microdissection. J Allergy Clin Immunol 2015;135:153-63. [PMID: 25567045 DOI: 10.1016/j.jaci.2014.10.037] [Cited by in Crossref: 118] [Cited by in F6Publishing: 117] [Article Influence: 16.9] [Reference Citation Analysis]
50 Glickman JW, Han J, Garcet S, Krueger JG, Pavel AB, Guttman-yassky E. Improving evaluation of drugs in atopic dermatitis by combining clinical and molecular measures. The Journal of Allergy and Clinical Immunology: In Practice 2020;8:3622-3625.e19. [DOI: 10.1016/j.jaip.2020.07.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
51 Manfredini M, Liberati S, Ciardo S, Bonzano L, Guanti M, Chester J, Kaleci S, Pellacani G. Microscopic and functional changes observed with dynamic optical coherence tomography for severe refractory atopic dermatitis treated with dupilumab. Skin Res Technol 2020;26:779-87. [DOI: 10.1111/srt.12868] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
52 Wang J, Suárez-fariñas M, Estrada Y, Parker ML, Greenlees L, Stephens G, Krueger J, Guttman-yassky E, Howell MD. Identification of unique proteomic signatures in allergic and non-allergic skin disease. Clin Exp Allergy 2017;47:1456-67. [DOI: 10.1111/cea.12979] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 5.4] [Reference Citation Analysis]
53 Ahmad HI, Jabbar A, Mushtaq N, Javed Z, Hayyat MU, Bashir J, Naseeb I, Abideen ZU, Ahmad N, Chen J. Immune Tolerance vs. Immune Resistance: The Interaction Between Host and Pathogens in Infectious Diseases. Front Vet Sci 2022;9:827407. [DOI: 10.3389/fvets.2022.827407] [Reference Citation Analysis]
54 Dyjack N, Goleva E, Rios C, Kim BE, Bin L, Taylor P, Bronchick C, Hall CF, Richers BN, Seibold MA, Leung DYM. Minimally invasive skin tape strip RNA sequencing identifies novel characteristics of the type 2-high atopic dermatitis disease endotype. J Allergy Clin Immunol 2018;141:1298-309. [PMID: 29309794 DOI: 10.1016/j.jaci.2017.10.046] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 12.0] [Reference Citation Analysis]
55 Renert-yuval Y, Guttman-yassky E. What’s New in Atopic Dermatitis. Dermatologic Clinics 2019;37:205-13. [DOI: 10.1016/j.det.2018.12.007] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 9.7] [Reference Citation Analysis]
56 Wang T, Zhang B, Li D, Qi X, Zhang C. Bioinformatic analysis of key pathways and genes involved in pediatric atopic dermatitis. Biosci Rep 2021;41:BSR20193517. [PMID: 33289509 DOI: 10.1042/BSR20193517] [Reference Citation Analysis]
57 Billi AC, Ludwig JE, Fritz Y, Rozic R, Swindell WR, Tsoi LC, Gruzska D, Abdollahi-Roodsaz S, Xing X, Diaconu D, Uppala R, Camhi MI, Klenotic PA, Sarkar MK, Husni ME, Scher JU, McDonald C, Kahlenberg JM, Midura RJ, Gudjonsson JE, Ward NL. KLK6 expression in skin induces PAR1-mediated psoriasiform dermatitis and inflammatory joint disease. J Clin Invest 2020;130:3151-7. [PMID: 32155135 DOI: 10.1172/JCI133159] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 12.0] [Reference Citation Analysis]
58 Glickman JW, Dubin C, Han J, Dahabreh D, Garcet S, Krueger JG, Pavel AB, Guttman-yassky E. Comparing cutaneous molecular improvement with different treatments in atopic dermatitis patients. Journal of Allergy and Clinical Immunology 2020;145:1285-8. [DOI: 10.1016/j.jaci.2020.01.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
59 Clayton K, Vallejo A, Sirvent S, Davies J, Porter G, Reading I, Lim F, Ardern‐jones M, Polak M. Machine learning applied to atopic dermatitis transcriptome reveals distinct therapy‐dependent modification of the keratinocyte immunophenotype*. Br J Dermatol 2021;184:913-22. [DOI: 10.1111/bjd.19431] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
60 Litman T. Personalized medicine-concepts, technologies, and applications in inflammatory skin diseases. APMIS 2019;127:386-424. [PMID: 31124204 DOI: 10.1111/apm.12934] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
61 Mikhaylov D, Glickman JW, Del Duca E, Nia J, Hashim P, Singer GK, Posligua AL, Florek AG, Ibler E, Hagstrom EL, Estrada Y, Rangel SM, Colavincenzo M, Paller AS, Guttman-Yassky E. A phase 2a randomized vehicle-controlled multi-center study of the safety and efficacy of delgocitinib in subjects with moderate-to-severe alopecia areata. Arch Dermatol Res 2022. [PMID: 35230488 DOI: 10.1007/s00403-022-02336-0] [Reference Citation Analysis]
62 Mansouri Y, Guttman-Yassky E. Immune Pathways in Atopic Dermatitis, and Definition of Biomarkers through Broad and Targeted Therapeutics. J Clin Med 2015;4:858-73. [PMID: 26239452 DOI: 10.3390/jcm4050858] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 9.3] [Reference Citation Analysis]
63 Zheng Y, Hou L, Wang XL, Zhao CG, Du Y. A review of nephrotic syndrome and atopic diseases in children. Transl Androl Urol 2021;10:475-82. [PMID: 33532335 DOI: 10.21037/tau-20-665] [Reference Citation Analysis]
64 Mao WB, Lyu JY, Vaishnani DK, Lyu YM, Gong W, Xue XL, Shentu YP, Ma J. Application of artificial neural networks in detection and diagnosis of gastrointestinal and liver tumors. World J Clin Cases 2020; 8(18): 3971-3977 [PMID: 33024753 DOI: 10.12998/wjcc.v8.i18.3971] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
65 Suárez-Fariñas M, Ungar B, Noda S, Shroff A, Mansouri Y, Fuentes-Duculan J, Czernik A, Zheng X, Estrada YD, Xu H, Peng X, Shemer A, Krueger JG, Lebwohl MG, Guttman-Yassky E. Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing. J Allergy Clin Immunol 2015;136:1277-87. [PMID: 26316095 DOI: 10.1016/j.jaci.2015.06.032] [Cited by in Crossref: 107] [Cited by in F6Publishing: 100] [Article Influence: 15.3] [Reference Citation Analysis]
66 Czarnowicki T, Dohlman AB, Malik K, Antonini D, Bissonnette R, Chan TC, Zhou L, Wen HC, Estrada Y, Xu H, Bryson C, Shen J, Lala D, Ma'ayan A, McGeehan G, Gregg R, Guttman-Yassky E. Effect of short-term liver X receptor activation on epidermal barrier features in mild to moderate atopic dermatitis: A randomized controlled trial. Ann Allergy Asthma Immunol 2018;120:631-640.e11. [PMID: 29567358 DOI: 10.1016/j.anai.2018.03.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
67 Mikhaylov D, Del Duca E, Olesen CM, He H, Wu J, Ungar B, Estrada Y, Zhang N, Chowdhury M, Clausen ML, Krueger JG, Pavel AB, Agner T, Guttman-Yassky E. Transcriptomic Profiling of Tape-Strips From Moderate to Severe Atopic Dermatitis Patients Treated With Dupilumab. Dermatitis 2021;32:S71-80. [PMID: 34405829 DOI: 10.1097/DER.0000000000000764] [Reference Citation Analysis]
68 Thijs JL, de Bruin-weller MS, Hijnen D. Current and Future Biomarkers in Atopic Dermatitis. Immunology and Allergy Clinics of North America 2017;37:51-61. [DOI: 10.1016/j.iac.2016.08.008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
69 Simpson EL, Silverberg JI, Nosbaum A, Winthrop KL, Guttman-Yassky E, Hoffmeister KM, Egeberg A, Valdez H, Zhang M, Farooqui SA, Romero W, Thorpe AJ, Rojo R, Johnson S. Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial Program. Am J Clin Dermatol 2021;22:693-707. [PMID: 34406619 DOI: 10.1007/s40257-021-00618-3] [Reference Citation Analysis]
70 Malik K, Ungar B, Garcet S, Dutt R, Dickstein D, Zheng X, Xu H, Estrada YD, Suárez-fariñas M, Shemer A, Krueger JG, Guttman-yassky E. Dust mite induces multiple polar T cell axes in human skin. Clin Exp Allergy 2017;47:1648-60. [DOI: 10.1111/cea.13040] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
71 Peng W, Novak N. Recent developments in atopic dermatitis. Curr Opin Allergy Clin Immunol 2014;14:417-22. [PMID: 25090248 DOI: 10.1097/ACI.0000000000000094] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
72 Chichelnitskiy E, Himmelseher B, Bachmann M, Pfeilschifter J, Mühl H. Hypothermia Promotes Interleukin-22 Expression and Fine-Tunes Its Biological Activity. Front Immunol 2017;8:742. [PMID: 28706520 DOI: 10.3389/fimmu.2017.00742] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
73 Paller AS, Renert-Yuval Y, Suprun M, Esaki H, Oliva M, Huynh TN, Ungar B, Kunjravia N, Friedland R, Peng X, Zheng X, Estrada YD, Krueger JG, Choate KA, Suárez-Fariñas M, Guttman-Yassky E. An IL-17-dominant immune profile is shared across the major orphan forms of ichthyosis. J Allergy Clin Immunol 2017;139:152-65. [PMID: 27554821 DOI: 10.1016/j.jaci.2016.07.019] [Cited by in Crossref: 69] [Cited by in F6Publishing: 53] [Article Influence: 11.5] [Reference Citation Analysis]
74 Brunner PM, Pavel AB, Khattri S, Leonard A, Malik K, Rose S, Jim On S, Vekaria AS, Traidl-hoffmann C, Singer GK, Baum D, Gilleaudeau P, Sullivan-whalen M, Fuentes-duculan J, Li X, Zheng X, Estrada Y, Garcet S, Wen H, Gonzalez J, Coats I, Cueto I, Neumann AU, Lebwohl MG, Krueger JG, Guttman-yassky E. Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumab. Journal of Allergy and Clinical Immunology 2019;143:142-54. [DOI: 10.1016/j.jaci.2018.07.028] [Cited by in Crossref: 61] [Cited by in F6Publishing: 60] [Article Influence: 20.3] [Reference Citation Analysis]
75 Czarnowicki T, Krueger JG, Guttman-yassky E. Skin Barrier and Immune Dysregulation in Atopic Dermatitis: An Evolving Story with Important Clinical Implications. The Journal of Allergy and Clinical Immunology: In Practice 2014;2:371-9. [DOI: 10.1016/j.jaip.2014.03.006] [Cited by in Crossref: 107] [Cited by in F6Publishing: 99] [Article Influence: 13.4] [Reference Citation Analysis]
76 Sanyal RD, Pavel AB, Glickman J, Chan TC, Zheng X, Zhang N, Cueto I, Peng X, Estrada Y, Fuentes-Duculan J, Alexis AF, Krueger JG, Guttman-Yassky E. Atopic dermatitis in African American patients is TH2/TH22-skewed with TH1/TH17 attenuation. Ann Allergy Asthma Immunol 2019;122:99-110.e6. [PMID: 30223113 DOI: 10.1016/j.anai.2018.08.024] [Cited by in Crossref: 64] [Cited by in F6Publishing: 65] [Article Influence: 16.0] [Reference Citation Analysis]
77 Ewald DA, Noda S, Oliva M, Litman T, Nakajima S, Li X, Xu H, Workman CT, Scheipers P, Svitacheva N, Labuda T, Krueger JG, Suárez-Fariñas M, Kabashima K, Guttman-Yassky E. Major differences between human atopic dermatitis and murine models, as determined by using global transcriptomic profiling. J Allergy Clin Immunol 2017;139:562-71. [PMID: 27702671 DOI: 10.1016/j.jaci.2016.08.029] [Cited by in Crossref: 65] [Cited by in F6Publishing: 61] [Article Influence: 10.8] [Reference Citation Analysis]
78 Sakaguchi M, Yamamoto M, Miyai M, Maeda T, Hiruma J, Murata H, Kinoshita R, Winarsa Ruma IM, Putranto EW, Inoue Y, Morizane S, Huh NH, Tsuboi R, Hibino T. Identification of an S100A8 Receptor Neuroplastin-β and its Heterodimer Formation with EMMPRIN. J Invest Dermatol 2016;136:2240-50. [PMID: 27388991 DOI: 10.1016/j.jid.2016.06.617] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
79 Weidinger S, Novak N. Atopic dermatitis. Lancet 2016;387:1109-22. [PMID: 26377142 DOI: 10.1016/S0140-6736(15)00149-X] [Cited by in Crossref: 815] [Cited by in F6Publishing: 280] [Article Influence: 116.4] [Reference Citation Analysis]
80 Bissonnette R, Pavel AB, Diaz A, Werth JL, Zang C, Vranic I, Purohit VS, Zielinski MA, Vlahos B, Estrada YD, Saint-cyr Proulx E, Ports WC, Guttman-yassky E. Crisaborole and atopic dermatitis skin biomarkers: An intrapatient randomized trial. Journal of Allergy and Clinical Immunology 2019;144:1274-89. [DOI: 10.1016/j.jaci.2019.06.047] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 7.7] [Reference Citation Analysis]
81 Chong M, Fonacier L. Treatment of Eczema: Corticosteroids and Beyond. Clin Rev Allergy Immunol 2016;51:249-62. [PMID: 25869743 DOI: 10.1007/s12016-015-8486-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
82 Pavel AB, Song T, Kim H, Del Duca E, Krueger JG, Dubin C, Peng X, Xu H, Zhang N, Estrada YD, Denis L, Rao N, Gupta S, Zammit DJ, Bissonnette R, Guttman-yassky E. Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis. Journal of Allergy and Clinical Immunology 2019;144:1011-24. [DOI: 10.1016/j.jaci.2019.07.013] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 12.3] [Reference Citation Analysis]
83 Leung DY, Guttman-Yassky E. Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches. J Allergy Clin Immunol 2014;134:769-79. [PMID: 25282559 DOI: 10.1016/j.jaci.2014.08.008] [Cited by in Crossref: 252] [Cited by in F6Publishing: 222] [Article Influence: 36.0] [Reference Citation Analysis]
84 Zhou L, Leonard A, Pavel AB, Malik K, Raja A, Glickman J, Estrada YD, Peng X, del Duca E, Sanz-cabanillas J, Ruano J, Xu H, Zhang N, Wen H, Gonzalez J, Garcet S, Krueger JG, Guttman-yassky E. Age-specific changes in the molecular phenotype of patients with moderate-to-severe atopic dermatitis. Journal of Allergy and Clinical Immunology 2019;144:144-56. [DOI: 10.1016/j.jaci.2019.01.015] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 12.7] [Reference Citation Analysis]
85 Renert-yuval Y, Guttman-yassky E. Systemic therapies in atopic dermatitis: The pipeline. Clinics in Dermatology 2017;35:387-97. [DOI: 10.1016/j.clindermatol.2017.03.012] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
86 Yasuda KI, Ishiuji Y, Endo T, Tanito K, Kamide R, Nobeyama Y, Asahina A. Cyclosporine Improves Sleep Quality in Patients with Atopic Dermatitis. Dermatol Ther (Heidelb) 2020;10:1359-69. [PMID: 32975744 DOI: 10.1007/s13555-020-00451-2] [Reference Citation Analysis]
87 Renert-yuval Y, Thyssen JP, Bissonnette R, Bieber T, Kabashima K, Hijnen D, Guttman-yassky E. Biomarkers in atopic dermatitis—a review on behalf of the International Eczema Council. Journal of Allergy and Clinical Immunology 2021;147:1174-1190.e1. [DOI: 10.1016/j.jaci.2021.01.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
88 Chew Y, Al-nema M, Ong VW. Management and treatment of atopic dermatitis with modern therapies, complementary and alternative medicines: a review. Orient Pharm Exp Med 2018;18:67-76. [DOI: 10.1007/s13596-018-0300-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
89 Czarnowicki T, Santamaria-babí LF, Guttman-yassky E. Circulating CLA + T cells in atopic dermatitis and their possible role as peripheral biomarkers. Allergy 2017;72:366-72. [DOI: 10.1111/all.13080] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
90 Kabashima K, Nomura T. Revisiting murine models for atopic dermatitis and psoriasis with multipolar cytokine axes. Curr Opin Immunol 2017;48:99-107. [PMID: 28915378 DOI: 10.1016/j.coi.2017.08.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
91 Wen H, Czarnowicki T, Noda S, Malik K, Pavel AB, Nakajima S, Honda T, Shin JU, Lee H, Chou M, Estrada Y, Zheng X, Xu H, Krueger JG, Lee K, Kabashima K, Guttman-yassky E. Serum from Asian patients with atopic dermatitis is characterized by T H 2/T H 22 activation, which is highly correlated with nonlesional skin measures. Journal of Allergy and Clinical Immunology 2018;142:324-328.e11. [DOI: 10.1016/j.jaci.2018.02.047] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 6.8] [Reference Citation Analysis]
92 Guttman-yassky E, Ungar B, Malik K, Dickstein D, Suprun M, Estrada YD, Xu H, Peng X, Oliva M, Todd D, Labuda T, Suarez-farinas M, Bissonnette R. Molecular signatures order the potency of topically applied anti-inflammatory drugs in patients with atopic dermatitis. Journal of Allergy and Clinical Immunology 2017;140:1032-1042.e13. [DOI: 10.1016/j.jaci.2017.01.027] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 5.6] [Reference Citation Analysis]
93 Hassan S, Hamideh N, Poulos C, Cheema S, Rangwani S, Lio PA. Atopic Dermatitis Biomarkers and the Movement Toward Personalized Treatment. Dermatitis 2021;32:S8-S14. [PMID: 34677167 DOI: 10.1097/DER.0000000000000711] [Reference Citation Analysis]
94 Oliva M, Renert-Yuval Y, Guttman-Yassky E. The 'omics' revolution: redefining the understanding and treatment of allergic skin diseases. Curr Opin Allergy Clin Immunol 2016;16:469-76. [PMID: 27490125 DOI: 10.1097/ACI.0000000000000306] [Cited by in Crossref: 29] [Cited by in F6Publishing: 8] [Article Influence: 5.8] [Reference Citation Analysis]
95 Kim M, Mikhaylov D, Rangel SM, Pavel AB, He H, Renert-Yuval Y, Del Duca E, Malik K, Huynh T, Ibler E, Sun M, Zhang N, Estrada Y, Krueger J, Paller AS, Guttman-Yassky E. Transcriptomic Analysis of the Major Orphan Ichthyosis Subtypes Reveals Shared Immune and Barrier Signatures. J Invest Dermatol 2022:S0022-202X(22)00269-X. [PMID: 35421402 DOI: 10.1016/j.jid.2022.03.022] [Reference Citation Analysis]
96 Guttman-Yassky E, Pavel AB, Zhou L, Estrada YD, Zhang N, Xu H, Peng X, Wen HC, Govas P, Gudi G, Ca V, Fang H, Salhi Y, Back J, Reddy V, Bissonnette R, Maari C, Grossman F, Wolff G. GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis. J Allergy Clin Immunol 2019;144:482-493.e7. [PMID: 30738171 DOI: 10.1016/j.jaci.2018.11.053] [Cited by in Crossref: 59] [Cited by in F6Publishing: 51] [Article Influence: 19.7] [Reference Citation Analysis]
97 Villani AP, Pavel AB, Wu J, Fernandes M, Maari C, Saint-Cyr Proulx E, Jack C, Glickman J, Choi S, He H, Ungar B, Estrada Y, Kameyama N, Zhang N, Gonzales J, Tardif JC, Krueger JG, Bissonnette R, Guttman-Yassky E. Vascular inflammation in moderate-to-severe atopic dermatitis is associated with enhanced Th2 response. Allergy 2021. [PMID: 33866573 DOI: 10.1111/all.14859] [Reference Citation Analysis]
98 Ruano J, Suárez-Fariñas M, Shemer A, Oliva M, Guttman-Yassky E, Krueger JG. Molecular and Cellular Profiling of Scalp Psoriasis Reveals Differences and Similarities Compared to Skin Psoriasis. PLoS One 2016;11:e0148450. [PMID: 26849645 DOI: 10.1371/journal.pone.0148450] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
99 Mühl H, Bachmann M. IL-18/IL-18BP and IL-22/IL-22BP: Two interrelated couples with therapeutic potential. Cell Signal 2019;63:109388. [PMID: 31401146 DOI: 10.1016/j.cellsig.2019.109388] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
100 Yoon J, Leyva-Castillo JM, Wang G, Galand C, Oyoshi MK, Kumar L, Hoff S, He R, Chervonsky A, Oppenheim JJ, Kuchroo VK, van den Brink MR, Malefyt Rde W, Tessier PA, Fuhlbrigge R, Rosenstiel P, Terhorst C, Murphy G, Geha RS. IL-23 induced in keratinocytes by endogenous TLR4 ligands polarizes dendritic cells to drive IL-22 responses to skin immunization. J Exp Med 2016;213:2147-66. [PMID: 27551155 DOI: 10.1084/jem.20150376] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 6.8] [Reference Citation Analysis]
101 Sokolowska M, Akdis CA. Highlights in immune response, microbiome and precision medicine in allergic disease and asthma. Curr Opin Immunol 2017;48:iv-x. [PMID: 29127996 DOI: 10.1016/j.coi.2017.10.009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
102 May RD, Fung M. Strategies targeting the IL-4/IL-13 axes in disease. Cytokine. 2015;75:89-116. [PMID: 26255210 DOI: 10.1016/j.cyto.2015.05.018] [Cited by in Crossref: 88] [Cited by in F6Publishing: 87] [Article Influence: 14.7] [Reference Citation Analysis]
103 Rozenblit M, Suarez-Farinas M, Shemer A, Khattri S, Gilleaudeau P, Sullivan-Whalen M, Zheng X, Xu H, Cardinale I, Krueger JG, Guttman-Yassky E. Residual genomic profile after cyclosporine treatment may offer insights into atopic dermatitis reoccurrence. J Allergy Clin Immunol 2014;134:955-7. [PMID: 24996261 DOI: 10.1016/j.jaci.2014.05.024] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
104 Renert-Yuval Y, Guttman-Yassky E. New treatments for atopic dermatitis targeting beyond IL-4/IL-13 cytokines. Ann Allergy Asthma Immunol 2020;124:28-35. [PMID: 31622669 DOI: 10.1016/j.anai.2019.10.005] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 15.7] [Reference Citation Analysis]